Abacavir/dolutegravir/lamivudine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideRenal toxicity: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2048卷 / 1期
关键词：
D O I：
10.1007/s40278-025-78234-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：14 / 14
相关论文
共 50 条
  • [1] Abacavir/dolutegravir/lamivudine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideVarious toxicities: 7 case reports
    Reactions Weekly, 2023, 1980 (1) : 14 - 14
  • [2] An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir plus abacavir/lamivudine
    Rogatto, Felipe
    Bouee, Stephane
    Jeanbat, Vivianne
    Piontkowsky, David
    Aragao, Filipa
    Bosse, Matthew
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 175 - 176
  • [3] Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamideRenal tubular acidosis: case report
    Reactions Weekly, 2020, 1793 (1) : 138 - 138
  • [4] Cobicistat/elvitegravir/emtricitabine/tenofovir/dolutegravir/raltegravirVarious toxicities: 10 case reports
    Reactions Weekly, 2019, 1769 (1) : 136 - 136
  • [5] An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine plus Dolutegravir in Initial Therapy
    Llibre, Josep M.
    Raffi, Francois
    Moyle, Graeme
    Behrens, Georg
    Bouee, Stephane
    Reilly, Geraldine
    Borg, Peter
    Piontkowsky, David
    Rogatto, Felipe
    PLOS ONE, 2016, 11 (05):
  • [6] Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience
    Chin, Bum Sik
    Lee, Jin-Hee
    Kim, Gayeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (29)
  • [7] Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016
    Perez Valero, Ignacio
    Cabello, Alfonso
    Ryan, Pablo
    De La Fuente-Moral, Sara
    Santos, Ignacio
    Jesus Vivancos, Maria
    Gonzalez, Alicia
    Gorgolas, Miguel
    Cuevas, Guillermo
    Diaz De Santiago, Alberto
    Cano, Joanna
    Rua, Guadalupe
    Yllescas, Maria
    Gonzalez Garcia, Juan Julian
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12):
  • [8] Atropine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideVarious toxicities: 2 case reports
    Reactions Weekly, 2022, 1922 (1) : 113 - 113
  • [9] Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamideReduced susceptibility to elvitegravir : case report
    Reactions Weekly, 2016, 1617 (1) : 72 - 72
  • [10] Reversibility of dolutegravir/lamivudine/abacavir neuropsychiatric toxicity after 24 weeks of switching to elvitegravir/cobicistat/emtricitabine/tenofovir-alafenamide (EVG/c/FTC/TAF). The DREAM Clinical Trial
    Perez Valero, I.
    Cabello, A.
    Ryan, P.
    de la Fuente Moral, S.
    Santos, I.
    Vivancos, M. J.
    Gorgolas, M.
    Cuevas, G.
    Diaz De Santiago, A.
    Garcia-Fraile, L.
    Bernardino, J. I.
    Valencia, E.
    Montes, M.
    Rua, G.
    Yllescas, M.
    Gonzalez, A.
    HIV MEDICINE, 2019, 20 : 90 - 91
12345